Effects of gonadotropin releasing hormone agonist addition to gonadotropin induction of ovulation in polycystic ovary syndrome patients
- 1 June 1992
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 45 (1), 53-58
- https://doi.org/10.1016/0028-2243(92)90193-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetateFertility and Sterility, 1990
- Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.BMJ, 1988
- The Effect of Leuprolide Acetate on Ovulation Induction with Human Menopausal Gonadotropins in Polycystic Ovary Syndrome*Journal of Clinical Endocrinology & Metabolism, 1987
- Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophinsBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phaseBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- The Use of Gonadotropins for Induction of OvulationFertility and Sterility, 1981
- The Use of Human Gonadotropins for the Induction of Ovulation in Women with Polycystic Ovarian DiseaseFertility and Sterility, 1980
- Cumulative conception rates following gonadotropin therapyAmerican Journal of Obstetrics and Gynecology, 1980
- The Use of Clomiphene CitrateFertility and Sterility, 1977